Who
Alan B. Bergman
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, 20/20 Biolabs; Chief Financial Officer, Smart For Life.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 10 Mar 2022
- Last trade
- 2 Apr 2026
- Last filed
- 6 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Apr 2026filed 6 Apr 2026 | AIDX 20/20 Biolabsoption or derivative · Professional Services | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Apr 2026filed 6 Apr 2026 | AIDX 20/20 Biolabsoption or derivative · Professional Services | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 6 Sep 2023filed 7 Sep 2023 | Smart For Lifeoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 5 Sep 2023filed 7 Sep 2023 | Smart For Lifeoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 12 Aug 2022filed 16 Aug 2022 | Smart For Lifeoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 10 Mar 2022filed 14 Mar 2022 | Smart For Life | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.